raloxifene hydrochloride has been researched along with Long QT Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Jin, MW; Li, GR; Liu, H; Sun, HY; Yang, L | 1 |
1 other study(ies) available for raloxifene hydrochloride and Long QT Syndrome
| Article | Year |
|---|---|
The selective estrogen receptor modulator raloxifene inhibits cardiac delayed rectifier potassium currents and voltage-gated sodium current without QTc interval prolongation.
Topics: Animals; Delayed Rectifier Potassium Channels; Electrocardiography; Ether-A-Go-Go Potassium Channels; Female; Guinea Pigs; HEK293 Cells; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Characteristics; Sodium Channels | 2010 |